Hinge Health, Inc. has raised its full year 2026 revenue guidance to a range of $818 million to $824 million, marking an increase of $20 million at the midpoint from its prior range and representing 40% year-over-year growth. The company now expects a non-GAAP operating margin of 27% at the midpoint for the fiscal year. This updated guidance reflects stronger-than-expected performance, driven by higher member conversion and improved performance across its client base, according to James Budge, Chief Financial Officer of Hinge Health.

For the second quarter of 2026, Hinge Health projects revenue to be between $200 million and $202 million, reflecting year-over-year growth of 45% at the midpoint. The company anticipates non-GAAP income from operations to be between $50 million and $52 million, corresponding to a non-GAAP operating margin of 25% at the midpoint. The full year 2026 non-GAAP income from operations is now expected to be between $217 million and $227 million.

Financial Outlook

The updated guidance incorporates stronger-than-expected performance across both quarterly and annual metrics. The company has not reconciled its non-GAAP income from operations and non-GAAP operating margin guidance to GAAP measures due to the uncertainty and potential variability of stock-based compensation expense, employer payroll tax expense related to stock-based compensation, amortization of intangible assets, and acquisition-related expenses.

Investor Day Details

Hinge Health will host its inaugural Investor Day on June 10, 2026, at 1:00 p.m. Central Time. The event will take place during Movement, the company's annual conference. Presentations will begin at 1:00 pm CT and will be available via webcast on Hinge Health's investor relations website. Investors will hear directly from company leaders regarding strategy and future opportunities. A replay of the webcast will be available for 12 months following the event.